Venus Concept nets $10 mln in funding from Longitude Capital
Venus Concept, a developer and manufacturer of devices for the medical aesthetic market, has secured $10 million in financing. The company's backer is U.S. venture capital firm Longitude Capital, which is focused on investing in medical technology and drug development companies. Funding proceeds will allow Venus Concept to further its R&D investments, strengthen sales operations in growing markets and implement its subscription-based business model worldwide. Led by a team of executives and researchers in the medical aesthetics industry, the Toronto-based company was founded in 2009.
23 May 2014•2 mins read
